Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1953 2
1954 2
1956 2
1967 2
1968 1
1969 1
1971 2
1975 3
1979 1
1980 2
1981 1
1982 2
1985 1
1986 1
1988 2
1991 1
1992 2
1993 1
1994 2
1995 2
1996 1
1997 3
1998 4
1999 3
2000 5
2001 1
2002 2
2003 5
2004 4
2005 4
2006 9
2007 3
2008 1
2009 1
2013 1
2015 1
2017 1
2018 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Natural history of Fabry disease.
Mehta A, Widmer U. Mehta A, et al. Among authors: widmer u. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry Disease: Perspectives from 5 Years of FOS. Oxford: Oxford PharmaGenesis; 2006. Chapter 19. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry Disease: Perspectives from 5 Years of FOS. Oxford: Oxford PharmaGenesis; 2006. Chapter 19. PMID: 21290671 Free Books & Documents. Review.
History of lysosomal storage diseases: an overview.
Mehta A, Beck M, Linhart A, Sunder-Plassmann G, Widmer U. Mehta A, et al. Among authors: widmer u. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry Disease: Perspectives from 5 Years of FOS. Oxford: Oxford PharmaGenesis; 2006. Chapter 1. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry Disease: Perspectives from 5 Years of FOS. Oxford: Oxford PharmaGenesis; 2006. Chapter 1. PMID: 21290707 Free Books & Documents. Review.
Efficacy of enzyme replacement therapy in Fabry disease.
Barbey F, Hayoz D, Widmer U, Burnier M. Barbey F, et al. Among authors: widmer u. Curr Med Chem Cardiovasc Hematol Agents. 2004 Oct;2(4):277-86. doi: 10.2174/1568016043356192. Curr Med Chem Cardiovasc Hematol Agents. 2004. PMID: 15320778 Review.
Progress towards Sustainable Control of Xylella fastidiosa subsp. pauca in Olive Groves of Salento (Apulia, Italy).
Scortichini M, Loreti S, Pucci N, Scala V, Tatulli G, Verweire D, Oehl M, Widmer U, Codina JM, Hertl P, Cesari G, De Caroli M, Angilè F, Migoni D, Del Coco L, Girelli CR, Dalessandro G, Fanizzi FP. Scortichini M, et al. Among authors: widmer u. Pathogens. 2021 May 29;10(6):668. doi: 10.3390/pathogens10060668. Pathogens. 2021. PMID: 34072394 Free PMC article. Review.
[Tubercular psoas abscess].
Buchholz S, Marti D, Schulthess G, Widmer U. Buchholz S, et al. Among authors: widmer u. Dtsch Med Wochenschr. 2000 Jul 14;125(28-29):866-8. doi: 10.1055/s-2000-7018. Dtsch Med Wochenschr. 2000. PMID: 10943217 German.
[Adult progeria (Werner's syndrome)].
Schulthess G, Osterwalder P, Widmer U, Hoffmann U. Schulthess G, et al. Among authors: widmer u. Dtsch Med Wochenschr. 1999 Mar 19;124(11):314-20. doi: 10.1055/s-2007-1024300. Dtsch Med Wochenschr. 1999. PMID: 10209532 German.
Kidney transplantation in patients with Fabry disease.
Cybulla M, Walter KN, Schwarting A, Divito R, Feriozzi S, Sunder-Plassmann G; European FOS Investigators Group. Cybulla M, et al. Transpl Int. 2009 Apr;22(4):475-81. doi: 10.1111/j.1432-2277.2008.00824.x. Epub 2009 Jan 22. Transpl Int. 2009. PMID: 19207191 Free article.
Severe lymphatic microangiopathy in Fabry disease.
Amann-Vesti BR, Gitzelmann G, Widmer U, Bosshard NU, Steinmann B, Koppensteiner R. Amann-Vesti BR, et al. Among authors: widmer u. Lymphat Res Biol. 2003;1(3):185-9. doi: 10.1089/153968503768330229. Lymphat Res Biol. 2003. PMID: 15624436
85 results